In‐depth research on the regulatory mechanisms of the PI3K/AKT/mTOR pathway in renal cancer holds immense potential in elucidating the molecular pathological mechanisms of renal cancer and developing new therapeutic strategies and drug targets. Here, AKT1 is linked to renal carcinoma.